Close Menu
    What's Hot

    Apex Capital Partners Completes Sale of Life Settlement Portfolio for Institutional Seller

    27 June 2025

    Milliken Industrials Limited Pension Plan Completes Bulk Purchase Annuity Transaction With Royal London

    27 June 2025

    Baker Hughes Completes Bulk Purchase Annuity Buy-Ins for Three Schemes With PIC

    27 June 2025
    Facebook X (Twitter) Instagram
    Instagram LinkedIn X (Twitter)
    Life Risk News
    • Home
    • Features

      Both Demand and Supply Factors Contribute to Rare Secondary Market Pullback in 2024

      12 June 2025

      Funded Reinsurance Under Scrutiny But Should Remain a Feature of the UK Pension risk Transfer Market

      12 June 2025

      Plenty of Guardrails for US Life Insurers Backing Group Annuities With Private Assets

      12 June 2025

      Liver Disease Mortality in England Continues to Worsen but General Mortality Still on a Post-Covid Downward Trend

      12 June 2025

      Q&A: Matthew Sheridan, Health Data Analytics

      12 June 2025
    • Commentary

      Life Expectancy in Breast Cancer

      12 June 2025

      The Healthy Wealthy Population of the Life Settlement Market

      12 June 2025

      UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025

      14 May 2025

      The Power of Uncorrelated Diversification During Market Volatility

      14 May 2025

      Overseeing BPA Growth Safely

      14 May 2025
    • Events
    • Magazine
    • News

      Apex Capital Partners Completes Sale of Life Settlement Portfolio for Institutional Seller

      27 June 2025

      Milliken Industrials Limited Pension Plan Completes Bulk Purchase Annuity Transaction With Royal London

      27 June 2025

      Baker Hughes Completes Bulk Purchase Annuity Buy-Ins for Three Schemes With PIC

      27 June 2025

      Lighthouse Life Announces Acquisition of ClearLife Limited

      24 June 2025

      Competitive Pension Risk Transfer Cost Decreases During May

      23 June 2025
    Subscribe
    Life Risk News
    Home » Q&A: Shelly Beard, Managing Director, WTW

    Q&A: Shelly Beard, Managing Director, WTW

    Features 14 May 2025Greg WintertonBy Greg Winterton
    Twitter LinkedIn Email
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    The UK pension risk transfer (PRT) market has delivered – yet again – a high-activity start to the year, with two new insurers entering the market, and deals aplenty being completed. Greg Winterton spoke to Shelly Beard, Managing Director at WTW, to get her views on the state of play in the market as we approach the halfway point of 2025. 

    GW: Shelly, to begin, 2024 delivered many transactions in the small and large ends of the market – almost a barbell type situation. What about the middle market? Has this part of the space seen any pick-up? 

    SB: Whilst 2024 may not have been quite as busy in the “mid-market”, this continues to be a busy sector and one that is well served by the insurance market. It’s fair to say it gets less “noise” than the other ends of the market that you’ve highlighted, with insurers spending a lot of 2024 shouting about how far they’ve come in terms of their offerings for small schemes, which had become an underserved part of the market in recent years.   

    In fact, I’d say right now, deals between £0.5bn and £1.5bn are probably the most hotly competed part of the market, achieving a large number of quotes (e.g. we had nine insurers quoting on a recent deal) and some highly attractive pricing. This reflects the fact that as well as the established insurers quoting for this size of transaction, many of the insurers who have traditionally focused on the smaller end of the market have now increased their ambitions for larger deals, which is shaking things up. 

    GW: There have been three new insurers enter the UK market in the past year; two of them in 2025. What’s your view on just how many more the market could realistically feature? 

    SB: You’re right, we now have more insurers actively quoting on deals than ever before. This is good news in the short term for pension schemes, as those insurers need to offer compelling pricing in order to establish themselves in the market. Further, more choice for trustees can only be a good thing, with the new entrants seeking to differentiate themselves across aspects such as speed of transition to buyout and member experience. 

    From speaking to the new insurers, most have relatively modest ambitions in terms of the amount of business that they wish to write over the next few years, so alongside expectations that the total volumes of business across the market will continue at similar (or higher) levels, I think there’s space for all of the insurers. 

    In terms of whether further new insurers could enter, I think that whilst there is capacity in the market, such a new entrant would need to think about their USPs and offer something new to be able to stand out from the crowd.  

    GW: We spoke at the end of last year for an article about longevity swaps. What have you seen in this part of the market at the start of this year? Has activity ticked up at all? 

    SB: It’s actually been an incredibly busy 12 months in the longevity swap market, with six deals covering more than £16bn of liabilities transacting. When we spoke late last year, I had to be a bit coy about deals we’d led but which hadn’t been publicly announced: Sorry about that! A key feature of last year was increased focus from the market in smaller deal sizes, at attractive pricing, demonstrating that longevity swaps aren’t only for mega schemes.  

    This theme of a busy market has continued into 2025, with a good level of activity expected across the rest of the year and the reinsurers continuing to show good appetite for new deals.  

    As and when more clarity is provided by the government on potential surplus sharing arrangements, to the extent this may lead to more schemes actively considering “running on” for a period, we expect there to be an extra pick up in longevity swap activity, as longevity risk is generally regarded as unrewarded, and so a good risk to remove in the context of run-on. 

    GW: There was plenty of talk at the beginning of this year about the buy-in to buy-out conversion. What’s been happening here so far in 2025? 

    SB: This is very much still a hot topic in the industry. As it stands, whilst 200-300 buy-ins are written each year, the number of buy-ins that are then converted to buyout is substantially lower – so there is a significant backlog building up. This is something we’re actively keeping an eye on – for example we recently undertook a detailed survey to ensure we understand the approach that insurers take to supporting their clients during this crucial period. 

    That’s not to say that insurers are necessarily at fault here, however. The burden on pension scheme administrators is ever growing, which can mean that they may struggle to keep up with the additional actions needed between buy-in and buyout. For example, to undertake thorough data cleansing and equalising GMP. In my experience it’s really important that all parties are realistic about what is achievable, bearing in mind the work that needs to be completed and any resource constraints. 

    GW: Lastly, Shelly, what’s the outlook for alternative risk transfer offerings through the balance of the year? It seems like this part of the market is like a car with the accelerator pedal down but the handbrake on – it’s forever ready to go but doesn’t seem to actually take off. 

    SB: I like the analogy. In practice I think this may be the year that the handbrake comes off, albeit I think the foot on the accelerator is a cautious one! Thinking for example of the superfund market, the Wates transaction at the end of last year, which was the first deal for Clara where the pension scheme had the support of an ongoing sponsor, was a big turning point and we have seen a significant increase in interest from clients as a result of this deal. And the Pensions Regulator and DWP continue to show their support for superfunds and consolidation in general. It will certainly be interesting to see how many more deals come to fruition. 

    Shelly Beard is Managing Director at WTW 

    2025 - May Longevity and Mortality Risk Transfer Longevity Risk Pension Risk Transfer Q&A Volume 4 Issue 5 - May 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Both Demand and Supply Factors Contribute to Rare Secondary Market Pullback in 2024

    12 June 2025

    Funded Reinsurance Under Scrutiny But Should Remain a Feature of the UK Pension risk Transfer Market

    12 June 2025

    Plenty of Guardrails for US Life Insurers Backing Group Annuities With Private Assets

    12 June 2025

    Liver Disease Mortality in England Continues to Worsen but General Mortality Still on a Post-Covid Downward Trend

    12 June 2025

    Comments are closed.

    Most Popular

    Both Demand and Supply Factors Contribute to Rare Secondary Market Pullback in 2024

    12 June 2025

    Funded Reinsurance Under Scrutiny But Should Remain a Feature of the UK Pension risk Transfer Market

    12 June 2025

    Plenty of Guardrails for US Life Insurers Backing Group Annuities With Private Assets

    12 June 2025

    Liver Disease Mortality in England Continues to Worsen but General Mortality Still on a Post-Covid Downward Trend

    12 June 2025
    Ad

    Your trusted source for capital markets participation in Life Risk

    X (Twitter) Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Terms and Conditions
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT